Follow us on


The latest developments in personalising healthcare. This is what’s happening in the world of MyCartis.


Come and visit us at Biotechnika 6-8 Oktober 2015

6-8 OKTOBER 2015 at the DEUTSCHE MESSE in Hannover ( You can find MyCartis here: B-9052 Zwijnaarde, Halle 9, Stand A59 7 Oktober 11.30 – 12.00 AM Speaker MyCartis: Wouter Laroy, “Personalized medicine: the need for next generation biomarker tools”

> Read more
logo medica

MyCartis at Medica

Only few days to go before the MEDICA starts. MyCartis is always interested to talk to potential partners and distributors so contact us directly for an appointment or visit us at booth J74 in Hall 3, Belgium Pavilion, where we will…

> Read more
the MyCartis

About MyCartis
Biomarker analysis
designed to make
healthcare personal

At MyCartis we believe that every individual has the right to good health. But we know that the current healthcare model of ‘one size fits all’ is insufficient and unsustainable. To continue to be effective, healthcare needs a radical change in the way it sees health and disease. That radical change is the personalization of healthcare. Something that requires a fundamentally new way of looking at things, a healthcare revolution.

> Read more



MyCartis technologies: accelerate innovation in biomarker analysis

MyCartis constantly develops technologies that push healthcare towards the next level of personalization. Not by ourselves, but by being part of a bigger network where we share ideas, knowledge and expertise. This allows us to accelerate innovation.

> Evalution™

MyCartis applications: improve bioassays

MyCartis is committed to provide disruptive solutions in the fields of clinical and translational research for its customers and partners. By making biomarker assays simpler and faster, healthcare is already becoming more personalised.

> Biomarkers

Evalution™ - the multiplexed analysis of biomarkers made fast and simple

Accelerate your research, trust your results
Evalution™ is MyCartis’ multiplex analysis platform tailored to the development of clinical biomarkers. It has been designed to analyze a broad range of protein and nucleic- acid based biomarkers to delivers high quality data and rapid results from minimal handling steps with unprecedented ease. Evalution™ integrates into a single instrument all the functions of incubation, washing, and optical readout for seamless operation of sophisticated assay protocols. The combination of customizable encoded microparticles with microfluidic assay plates in Evalution™ enables the combined analysis of protein and nucleic-acid biomarkers simultaneously. The platform Evalution is intended for research use only – Not for diagnostic procedure

> More Evalution™

MyCartis biomarker innovations

Protocols have been developed that enable a large variety of applications for the detection of proteins and nucleic acids such as sandwich immunoassays, (auto) antibody assays, genotyping, mutation analysis, m(i)RNA profiling. Novel proprietary biomarkers are in a late stage of protein biomarker pipeline and dedicated panels are in development for their validation. In parallel MyCartis is also developing research kits for a number of disease areas as part of it’s product pipeline.

> Biomarker innovations
> Solutions

Our partners in the healthcare revolution

Changing healthcare is not something we do on our own. MyCartis strongly believes in co-creation. By sharing ideas, knowledge, and expertise with our selected partners we realise our joint ambition of improving healthcare for future generations. Right now we are looking for new partners to accelerate the personalisation of healthcare.

> Find out more